Patients were 42 % more likely to be well-controlled ( ACT score 20 ) with FF 200 g than with FF 100 g. Slightly more patients receiving FF 200 g vs. FF 100 g reported adverse events ( 63 % vs. 59 % ) and events deemed treatment related ( 5 % vs. < 1 % ) .